1. Home
  2. RAIL vs PLX Comparison

RAIL vs PLX Comparison

Compare RAIL & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FreightCar America Inc.

RAIL

FreightCar America Inc.

HOLD

Current Price

$7.84

Market Cap

149.9M

Sector

Industrials

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.09

Market Cap

174.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAIL
PLX
Founded
1901
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.9M
174.0M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
RAIL
PLX
Price
$7.84
$2.09
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
139.3K
543.9K
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
134.94
N/A
EPS
1.15
N/A
Revenue
$500,991,000.00
$52,744,000.00
Revenue This Year
$6.54
$36.81
Revenue Next Year
$30.90
N/A
P/E Ratio
$7.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.02
$1.34
52 Week High
$14.90
$3.19

Technical Indicators

Market Signals
Indicator
RAIL
PLX
Relative Strength Index (RSI) 33.65 35.59
Support Level $7.78 $2.03
Resistance Level $10.09 $2.14
Average True Range (ATR) 0.46 0.06
MACD -0.04 -0.00
Stochastic Oscillator 21.05 1.65

Price Performance

Historical Comparison
RAIL
PLX

About RAIL FreightCar America Inc.

FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

Share on Social Networks: